The effects and side effects of laquinimod for the treatment of multiple sclerosis patients: a systematic review and meta-analysis of clinical trials
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00228-019-02827-6.pdf
Reference30 articles.
1. Constantinescu SE, Constantinescu CS (2016) Laquinimod (ABR-215062) for the treatment of relapsing multiple sclerosis. Expert Rev Clin Pharmacol 9(1):49–57. https://doi.org/10.1586/17512433.2016.1108189
2. Adelman G, Rane SG, Villa KF (2013) The cost burden of multiple sclerosis in the United States: a systematic review of the literature. J Med Econ 16(5):639–647. https://doi.org/10.3111/13696998.2013.778268
3. Siddiqui MK, Khurana IS, Budhia S et al (2018) Systematic literature review and network meta-analysis of cladribine tablets versus alternative disease-modifying treatments for relapsing-remitting multiple sclerosis. Curr Med Res Opin 34(8):1361–1371. https://doi.org/10.1080/03007995.2017.14073034
4. Thone J, Linker RA (2016) Laquinimod in the treatment of multiple sclerosis: a review of the data so far. Drug Des Devel Ther 10:1111–1118. https://doi.org/10.2147/DDDT.S55308
5. Sørensen PS, Comi G, Vollmer TL et al (2017) Laquinimod safety profile: pooled analyses from the ALLEGRO and BRAVO trials. Int J MS Care 19(1):16–24. https://doi.org/10.7224/1537-2073.2015-024
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Headache in Multiple Sclerosis: A Narrative Review;Medicina;2024-03-30
2. Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target;Frontiers in Immunology;2022-09-23
3. Carboxamide Derivatives Are Potential Therapeutic AHR Ligands for Restoring IL-4 Mediated Repression of Epidermal Differentiation Proteins;International Journal of Molecular Sciences;2022-02-04
4. Orofacial pain considerations in autoimmune disorders: narrative review;Frontiers of Oral and Maxillofacial Medicine;2022-01
5. Dendritic Cell–Targeted Therapies to Treat Neurological Disorders;Molecular Neurobiology;2021-11-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3